Background and Purpose: Adverse side effects of conventional opioids can be avoided if ligands selectively activate peripheral opioid receptors in injured tissue. Injury and inflammation are typically accompanied by acidification. In this study, we examined influences of low pH and mutation of the ionizable amino acid residue H297(6.52) on mu-opioid receptor binding and signalling induced by the mu-opioid receptor ligands fentanyl, DAMGO, and naloxone.
Experimental Approach: HEK 293 cells stably transfected with mu-opioid receptors were used to study opioid ligand binding, [S-35]-GTP gamma S binding, and cAMP reduction at physiological and acidic pH. We used mu-opioid receptors mutated at H297(6.52) to A (MOR-H297(6.52)A) to delineate ligand-specific interactions with H297(6.52).
Key Results: Low pH and the mutant receptor MOR-H297(6.52)A impaired naloxone binding and antagonism of cAMP reduction. In addition, DAMGO binding and G-protein activation were decreased under these conditions. Fentanyl-induced signalling was not influenced by pH and largely independent of H297(6.52).
Conclusions and Implications: Our investigations indicate that low pH selectively impairs mu-opioid receptor signalling modulated by ligands capable of forming hydrogen bonds with H297(6.52). We propose that protonation of H297(6.52) at acidic pH reduces binding and subsequent signalling of such ligands. Novel agonists targeting opioid receptors in injured tissue might benefit from lack of hydrogen bond formation with H297(6.52).
